<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05107414</url>
  </required_header>
  <id_info>
    <org_study_id>20203268</org_study_id>
    <nct_id>NCT05107414</nct_id>
  </id_info>
  <brief_title>Journey 2 Multi Center Kinematic Study</brief_title>
  <official_title>Multi-center In Vivo Kinematics for Subjects Implanted With Smith &amp; Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Tennessee, Knoxville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Tennessee, Knoxville</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine and compare the in vivo kinematics and&#xD;
      vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized&#xD;
      (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">January 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Femorotibial Medial Condylar Rollback</measure>
    <time_frame>Baseline, at time of observation</time_frame>
    <description>The condylar rollback of the medial condyle will be observed at a single instance in time. Participants will have previously undergone a total knee arthroplasty but data cannot be collected on their preoperative kinematics. Outcome will be measured in [mm].</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Femorotibial Lateral Condylar Rollback</measure>
    <time_frame>Baseline, at time of observation</time_frame>
    <description>The condylar rollback of the lateral condyle will be observed at a single instance in time. Participants will have previously undergone a total knee arthroplasty but data cannot be collected on their preoperative kinematics. Outcome will be measured in [mm].</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Femorotibial Axial Rotation</measure>
    <time_frame>Baseline, at time of observation</time_frame>
    <description>The femorotibial axial rotation will be observed at a single instance in time. Participants will have previously undergone a total knee arthroplasty but data cannot be collected on their preoperative kinematics. Outcome will be measured in [deg].</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Femorotibial Weight Bearing Flexion</measure>
    <time_frame>Baseline, at time of observation</time_frame>
    <description>The femorotibial weight bearing flexion will be observed at a single instance in time. Participants will have previously undergone a total knee arthroplasty but data cannot be collected on their preoperative kinematics. Outcome will be measured in [deg].</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Journey II Bi-Cruciate Stabilized</arm_group_label>
    <description>Participants who have been implanted with a Smith &amp; Nephew Journey II BCS TKA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Journey II Cruciate Retaining</arm_group_label>
    <description>Participants who have been implanted with a Smith &amp; Nephew Journey II CR TKA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Journey II Bi-Cruciate Retaining</arm_group_label>
    <description>Participants who have been implanted with a Smith &amp; Nephew Journey II BCR TKA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total Knee Arthroplasty</intervention_name>
    <description>Participants have previously undergone a total knee replacement surgery.</description>
    <arm_group_label>Journey II Bi-Cruciate Retaining</arm_group_label>
    <arm_group_label>Journey II Bi-Cruciate Stabilized</arm_group_label>
    <arm_group_label>Journey II Cruciate Retaining</arm_group_label>
    <other_name>Smith &amp; Nephew Journey II TKA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All participants will be selected by their respective surgeons. Participants will be&#xD;
        screened by eligible surgeon staff and will have the required implant for each site.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients in the age range of 18 years to 85 years (both inclusive)&#xD;
&#xD;
          2. Patients who have a BMI less than 35&#xD;
&#xD;
          3. Patients who do not have previous surgery on the implanted knee that might restrict&#xD;
             their movement&#xD;
&#xD;
          4. Patient who are at least 6 months post-operative&#xD;
&#xD;
          5. Patients who do not experience any pain or other post-operative complications&#xD;
&#xD;
          6. Patients who have a stable TKA and can perform a deep knee bend activity&#xD;
&#xD;
          7. Patients who are willing to participate in this study and are willing to sign&#xD;
             appropriate HIPAA and informed consent forms&#xD;
&#xD;
          8. Subjects will have a Journey II knee system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant, potentially pregnant, or lactating females. To satisfy radiation protocol,&#xD;
             each female subject will be asked if she is pregnant, or possibly could be pregnant. A&#xD;
             pregnant person will not be allowed to participate in the study.&#xD;
&#xD;
          2. Patients who have currently enrolled in a fluoroscopic study within the past year.&#xD;
&#xD;
          3. Patients currently involved in any personal injury litigation, medical/legal or&#xD;
             workman's compensation claims.&#xD;
&#xD;
          4. Patients with known drug or alcohol abuse histories or psychological disorders that&#xD;
             could affect ability to complete all aspects of the study.&#xD;
&#xD;
          5. Patients with neurological or musculoskeletal disorders that might adversely affect&#xD;
             weight-bearing motion ability&#xD;
&#xD;
          6. Subjects who are unable to perform a deep knee bend.&#xD;
&#xD;
          7. Subjects who are unwilling to sign Informed Consent/ HIPAA documents.&#xD;
&#xD;
          8. Subjects without the required type of knee implant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Michael LaCour, PhD</last_name>
    <phone>(865) 974-2093</phone>
    <email>mlacour@utk.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Komistek, PhD</last_name>
    <email>rkomiste@utk.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37996</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael LaCour, PhD</last_name>
      <phone>865-974-2093</phone>
      <email>mlacour@utk.edu</email>
    </contact>
    <investigator>
      <last_name>Michael LaCour, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>October 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

